Stay updated on Nivolumab Ipilimumab RT for Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page
- Check4 days agoChange Detected- Displayed Revision: v3.5.5 replaces v3.5.4 in the page header, indicating a frontend version update. - This change is limited to metadata and does not alter the study details presented on the page.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page's revision marker was updated from v3.5.3 to v3.5.4, indicating a version update in the page's metadata.SummaryDifference0.0%

- Check47 days agoChange DetectedThis updates the site’s displayed revision/version label for the ClinicalTrials.gov page (from v3.5.2 to v3.5.3) without changing the study content.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check69 days agoChange DetectedAdded the term Malignant fibrous histiocytoma to related terms and added Genetic and Rare Diseases Information Center as a resources reference.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No visible changes to core study details or user-facing content.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Ipilimumab RT for Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page.